Sharan Sharat 10b5-1 Sale: 37,982 ONTF Shares Sold at $4.87 Avg
Rhea-AI Filing Summary
Sharan Sharat, identified as President and Chief Executive, a director and a 10% owner of ON24, Inc. (ONTF), reported insider transactions dated 08/11/2025. The Form 4 shows an exercise of 62,206 option-derived shares at a stated conversion/exercise price of $0.89, and a sale of 37,982 common shares at a weighted average price of $4.8731 executed under a Rule 10b5-1 trading plan adopted on December 12, 2024.
Following the reported transactions the filing lists beneficial ownership figures of 3,637,545 and 3,599,563 shares on the two report lines; the form also states the related options are fully vested and exercisable. The seller notes the sale occurred in multiple transactions with prices ranging $4.78 to $4.94.
Positive
- Exercise of 62,206 options at a stated conversion/exercise price of $0.89, resulting in additional common shares recorded.
- Options are fully vested and exercisable, as explicitly stated in the filing.
- Transactions were executed under a documented Rule 10b5-1 trading plan adopted on December 12, 2024, and the filer disclosed this in the explanation.
Negative
- Sale of 37,982 shares reported at a weighted average price of $4.8731, which reduced the reporting person's beneficial holdings on the reporting lines.
- The sale was executed in multiple transactions with prices ranging from $4.78 to $4.94, per the footnote.
- Form was signed by an attorney-in-fact rather than the reporting person, as indicated on the signature block.
Insights
TL;DR: Insider exercised 62,206 options at $0.89 and sold 37,982 shares at a $4.8731 weighted average under a 10b5-1 plan.
The filing documents a two-part transaction: an option exercise converting 62,206 derivative securities into common stock at a $0.89 exercise/conversion price, and a contemporaneous sale of 37,982 shares that reported a weighted average sale price of $4.8731. The sale was effected under a Rule 10b5-1 plan adopted on December 12, 2024, and the filer states the sales occurred across multiple transactions priced between $4.78 and $4.94. The options are noted as fully vested and exercisable. Impact is informational for share count and insider liquidity; no additional corporate performance data is included in the filing.
TL;DR: Pre-arranged 10b5-1 plan and attorney-in-fact signature; transaction adjusts insider holdings modestly.
The Form 4 indicates the transactions were conducted pursuant to a Rule 10b5-1 trading plan and the filing bears an attorney-in-fact signature on behalf of the reporting person. The document shows an acquisition via exercise of 62,206 option-derived shares and a sale of 37,982 shares, with post-transaction beneficial ownership figures reported as 3,637,545 and 3,599,563 on the two lines. The options related to the exercise are explicitly stated to be fully vested and exercisable. From a governance perspective, the use of a 10b5-1 plan and an attorney-in-fact are material procedural details; the filing does not disclose additional governance changes or material corporate actions.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 62,206 | $0.00 | -- |
| Exercise | Common Stock | 62,206 | $0.89 | $55K |
| Sale | Common Stock | 37,982 | $4.8731 | $185K |
Footnotes (1)
- The transaction reported in this Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by the reporting person on December 12, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $4.78 to $4.94 inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in footnote (2) to this Form 4. The options are fully vested and exercisable.
